DiaMedica Therapeutics Inc. (DMAC) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -9.08M | -7.76M | -6.6M | -7.6M | -7.15M | -6.43M | -4.47M | -4.52M | -6.65M | -3.81M | -4.8M | -5.03M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -27.04% | -20.69% | -47.76% | -68.13% | -7.46% | -68.78% | 6.82% | 10.16% | -30.73% | -37.82% | -103.18% | -101.52% |
| Net Income | -10.04M | -8.74M | -8.62M | -7.7M | -7.71M | -7.9M | -6.27M | -5.12M | -5.15M | -5.16M | -4.47M | -4.48M |
| Depreciation & Amortization | 11K | 20K | 18K | 3K | 11K | 11K | 10K | 10K | 8K | 8K | 8K | 7K |
| Stock-Based Compensation | 0 | 1.19M | 0 | 771K | 867K | 589K | 565K | 443K | 488K | 456K | 425K | 380K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 654K | -240K | 712.11K | -160K | -241K | -311K | -346K | -300K | -311K | -349K | -406K | -210K |
| Working Capital Changes | 295K | 3K | 1.29M | -513K | -79K | 1.18M | 1.57M | 447K | -1.69M | 1.23M | -353K | -730K |
| Change in Receivables | -43K | 2K | -100.73K | 92K | -17K | 54K | 101K | 8K | -30K | -59K | -122K | -131K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.82M | -445K | 668.05K | -246K | 567K | -231K | 412K | 43K | -210K | 63K | 7K | -924K |
| Cash from Investing | -2.11M | 8M | -26.21M | 8.96M | 6.62M | 5.21M | -5.58M | 4.74M | 4.21M | 6.12M | 1.2M | -28.13M |
| Capital Expenditures | -8K | -6K | -16.19K | -6K | -12K | -7K | -9K | 0 | -9K | -3K | -10K | -4K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 417K | 12.09M | 32.01M | 161K | 91K | 120K | 123K | 11.75M | -1K | -1K | -6K | 36.85M |
| Debt Issued (Net) | -3K | -2K | -3.03K | -2K | -3K | -3K | -3K | -2K | -1K | -1K | -2K | -2K |
| Equity Issued (Net) | 420K | 11.63M | 32.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 458.19K | -462.94K | 163K | 94K | 123K | 126K | 11.75M | 0 | 0 | 0 | 36.85M |
| Net Change in Cash | -10.78M | 12.32M | -783K | 1.52M | -436K | -1.11M | -9.93M | 11.97M | -2.45M | 2.31M | -3.61M | 3.69M |
| Free Cash Flow | -9.09M | -7.77M | -6.62M | -7.6M | -7.16M | -6.44M | -4.48M | -4.52M | -6.66M | -3.81M | -4.81M | -5.03M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -26.94% | -20.65% | -47.82% | -68.27% | -7.49% | -68.83% | 6.82% | 10.23% | -30.73% | -36.35% | -99.96% | -101.2% |
| FCF per Share | -0.17 | -0.17 | -0.13 | -0.18 | -0.17 | -0.15 | -0.10 | -0.12 | -0.18 | -0.10 | -0.13 | -0.18 |
| FCF Conversion (FCF/Net Income) | 0.90x | 0.89x | 0.77x | 0.99x | 0.93x | 0.81x | 0.71x | 0.88x | 1.29x | 0.74x | 1.07x | 1.12x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 10K | 0 | 6K | 6K | 6K | 6K | 7K | 7K | 7K | 6K | 6K |